1. Celgene Corporation

    0 Comments Leave a Comment

    1-10 of 10
    1. Mentioned In 10 Articles

    2. Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders

      Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders
      Bristol-Myers Squibb CompanysBMY,-1.55%Board of Directors today sent an open letter to the Companys shareholders regarding the previously announced definitive merger agreement with Celgene CorporationCELG,-1.65%In addition to its March 19 investor presentation, the Company today also made available on Bristol-Myers Squibbs website ...
      Read Full Article
    3. When An Activist Calls, What Do You Do? Surprising and Practical Answers at The Deal's Inaugural Corporate Governance Event

      When An Activist Calls, What Do You Do? Surprising and Practical Answers at The Deal's Inaugural Corporate Governance Event
      ... Manager, Starboard Value; Joseph Frumkin, Partner, Sullivan & Cromwell; Robert J. Hugin, Executive Chairman, Celgene Corporation; Eric Jackson, Managing Director, SpringOwl Asset Management; Paula Loop, Leader, PwC Gove...
      Read Full Article
    4. 1-10 of 10
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes about Celgene Corporation

    1. Bristol-Myers is deeply undervalued and the recent announcement of the Company's proposed acquisition of Celgene Corporation is poorly conceived and ill-advised.
      In Celgene Pops After Proxy Advisor ISS Recommends Bristol-Myers Investors Approve Buyout